89 related articles for article (PubMed ID: 31423511)
1. Prognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Han W; Cao F; Chen MB; Lu RZ; Wang HB; Yu M; Shi CT; Ding HZ
PLoS One; 2016; 11(1):e0145803. PubMed ID: 26731428
[TBL] [Abstract][Full Text] [Related]
2. HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review.
Wu T; Zhang W; Yang G; Li H; Chen Q; Song R; Zhao L
Oncotarget; 2016 Aug; 7(31):50417-50427. PubMed ID: 27391431
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of SPARC expression in gastric cancer: a meta-analysis.
Wang Z; Hao B; Yang Y; Wang R; Li Y; Wu Q
Arch Med Sci; 2014 Oct; 10(5):863-9. PubMed ID: 25395936
[TBL] [Abstract][Full Text] [Related]
4. Citric acid promotes SPARC release in pancreatic cancer cells and inhibits the progression of pancreatic tumors in mice on a high-fat diet.
Xiao G; Wei Y; Xie R; Tsang Y; Gu J; Shen D; Ding M; Yuan J; Xu D; Fei J
FEBS J; 2024 Apr; 291(8):1699-1718. PubMed ID: 38245817
[TBL] [Abstract][Full Text] [Related]
5. Matricellular proteins osteopontin and osteonectin/SPARC in pancreatic carcinoma.
Delany AM
Cancer Biol Ther; 2010 Jul; 10(1):65-7. PubMed ID: 20657168
[No Abstract] [Full Text] [Related]
6. Serum protein acidic and rich in cysteine (SPARC) as a prognostic marker in soft tissue sarcomas.
Morgan SS; Nagle RB; Cranmer LD
Clin Sarcoma Res; 2014 Jan; 4(1):2. PubMed ID: 24484617
[TBL] [Abstract][Full Text] [Related]
7. Phenotypical and potential functional characteristics of different immune cells expressing CD28H/B7-H5 and their relationship with cancer prognosis.
Zhong C; Lang Q; Yu J; Wu S; Xu F; Tian Y
Clin Exp Immunol; 2020 Apr; 200(1):12-21. PubMed ID: 31901178
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of tumor-associated macrophages in patients with nasopharyngeal carcinoma: A meta-analysis.
Chen YL
Medicine (Baltimore); 2020 Sep; 99(39):e21999. PubMed ID: 32991403
[TBL] [Abstract][Full Text] [Related]
9. Citrus fruit intake and the risk of nasopharyngeal carcinoma.
Feng XX; Wang MX; Li M; Tang X; Jiang H; Wang R; Ma L; Yin Y; Wu CR
Asia Pac J Clin Nutr; 2019; 28(4):783-792. PubMed ID: 31826376
[TBL] [Abstract][Full Text] [Related]
10. Nasopharyngeal Carcinoma (NPC) Risk Factors: A Systematic Review and Meta-Analysis of the Association with Lifestyle, Diets, Socioeconomic and Sociodemographic in Asian Region.
Okekpa SI; S M N Mydin RB; Mangantig E; Azmi NSA; Zahari SNS; Kaur G; Musa Y
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3505-3514. PubMed ID: 31759378
[TBL] [Abstract][Full Text] [Related]
11. Association of Chemoradiotherapy Regimens and Survival Among Patients With Nasopharyngeal Carcinoma: A Systematic Review and Meta-analysis.
Zhang B; Li MM; Chen WH; Zhao JF; Chen WQ; Dong YH; Gong X; Chen QY; Zhang L; Mo XK; Luo XN; Tian J; Zhang SX
JAMA Netw Open; 2019 Oct; 2(10):e1913619. PubMed ID: 31626318
[TBL] [Abstract][Full Text] [Related]
12. Investigating the relationship between secreted protein acidic and rich in cysteine expression level and therapeutic efficacy of nab-paclitaxel: a meta-analysis.
Zhou X; Zhang L; Qierang C; Huang M; Yang X; Li L; Jiang J
Transl Cancer Res; 2021 Feb; 10(2):876-885. PubMed ID: 35116417
[TBL] [Abstract][Full Text] [Related]
13. Pan-Cancer Analyses Reveal Prognostic Value of Osteomimicry Across 20 Solid Cancer Types.
Yang C; Pan H; Shen L
Front Mol Biosci; 2020; 7():576269. PubMed ID: 33240930
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of secreted protein acidic and rich in cysteine in patients with solid tumors.
Ma Y; Chen H; Ma H; Yao Z; Hu J; Ma J; Zhang X; Chen G; Liu Y
Saudi Med J; 2019 Aug; 40(8):755-765. PubMed ID: 31423511
[TBL] [Abstract][Full Text] [Related]
15. Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis.
Wang HY; Li YY; Shao Q; Hou JH; Wang F; Cai MB; Zeng YX; Shao JY
J Transl Med; 2012 Feb; 10():27. PubMed ID: 22321704
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of CXCL12 expression for cancer prognosis.
Samarendra H; Jones K; Petrinic T; Silva MA; Reddy S; Soonawalla Z; Gordon-Weeks A
Br J Cancer; 2017 Jun; 117(1):124-135. PubMed ID: 28535157
[TBL] [Abstract][Full Text] [Related]
17. The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab.
Meyer PN; Fu K; Greiner T; Smith L; Delabie J; Gascoyne R; Ott G; Rosenwald A; Braziel R; Campo E; Vose J; Lenz G; Staudt L; Chan W; Weisenburger DD
Am J Clin Pathol; 2011 Jan; 135(1):54-61. PubMed ID: 21173124
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of secreted protein acidic and rich in cysteine expression in breast cancer tissue and its association with prognosis.
Guo W; Zhang M; Chen Y; Guo S
J Cancer Res Ther; 2017; 13(5):833-836. PubMed ID: 29237913
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of SPARC Expression in Breast Cancer: A Meta-Analysis and Bioinformatics Analysis.
Shi S; Ma HY; Han XY; Sang YZ; Yang MY; Zhang ZG
Biomed Res Int; 2022; 2022():8600419. PubMed ID: 35211625
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
